The genistein saga — all data and no (good) results

The idea that the soy isoflavone known as genistein might prove to be a non-toxic therapeutic agent for the prevention and/or treatment of prostate cancer has now been around for so long that the idea appears to have become a perceived truth in some quarters. … READ MORE …

Soy isoflavones and radiation therapy: a pilot study

Soy isoflavones are known to have antioxidant and anti-inflammatory activities and to sensitize prostate cancer cells to radiation therapy. … READ MORE …

Wednesday’s news reports: February 25, 2009 — Part 2

Our second report today deals with:

  • Soy isoflavone concentration in prostate cancer tissue
  • A new vitamin E ether analog and its activity in the laboratory
  • PSA “half-life” as a prognostic indicator for impact of hormone therapy
  • Apolipoprotein C-I: is it important hormone-refractory prostate cancer?
  • Chemotherapeutic sensitization and its possible impact on taxane therapy … READ MORE …